Two case reports on the treatment of acute migraine with niacin: Its hypothetical mechanism of action upon calcitonin-gene related peptide and platelets

Journal of Orthomolecular Medicine

Volumn 18, Issue 2, 2003, Pages 108-110

  Prousky, Jonathan E ^a   Sykes, Erika ^b  

^a CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DRUG METABOLITE; NICOTINIC ACID; NICOTINIC ACID METHYL ESTER; PROSTAGLANDIN D2;

ADULT; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; DRUG MECHANISM; ECONOMIC ASPECT; FLUSHING; HEADACHE; HUMAN; MALE; MIGRAINE; PEPTIDE ANALYSIS; PROSTAGLANDIN RELEASE; THROMBOCYTE; THROMBOCYTE FUNCTION; TRIGEMINAL NERVE; VASODILATATION;

EID: 0043170840     PISSN: 03170209     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Aukerman G, Knutson D, Miser WF: Management of the acute migraine headache. Am Famil Phys, 2002; 66: 2123-2130, 2140-2141.
2. Hendler SS: The Doctor's Vitamin and Mineral Encyclopedia. New York. Simon & Schuster. 1991; 60.
3. Hall JA: Enhancing niacin's effect for migraine. Cortlandt Forum, 1991; July: 46.
4. Gedye A: Hypothesized treatment for migraine using low doses of tryptophan, niacin, calcium, caffeine, and acetylsalicylic acid. Med Hypotheses, 2001; 56: 91-94.
5. Shibata Y, Nishimoto Y, Takeuchi F, Tatsuma Y: Tryptophan metabolism in various nutritive conditions. Acta Vitamin Enzymol, 1973; 29: 190-193.
6. Maissen CP, Ludin HP. Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine. Schweiz Med Wochenschr, 1991; 121: 1585-1590.
7. Kangasniemi P, Falck B, Langvik VA, Hyyppa MT: Levotryptophan treatment in migraine. Headache, 1998; 38: 303-307.
8. Morrow JD, Parsons WG 3rd, Roberts LJ: Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins, 1989; 38: 263-274.
9. Morrow JD, Awad JA, Oates JA, et al: Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol, 1992; 98: 812-815.
10. Jenkins DW, Feniuk W, Humphrey PP: Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol, 2001; 134: 1296-1302.
11. Mezei Z, Kis B, Gecse A, et al: Platelet arachidonate cascade of migraineurs in the interictal phase. Platelets, 2000; 11: 222-225.